The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment

被引：3
作者：
Gaebel, Wolfgang [1 ,2 ]
Stricker, Johannes [1 ,2 ]
Hasan, Alkomiet [3 ]
Falkai, Peter [4 ]
McIntyre, John S. [5 ]
Kerst, Ariane [1 ,2 ]
机构：
[1] Heinrich Heine Univ, LVR Klinikum Dusseldorf, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[2] WHO Collaborating Ctr Qual Assurance & Empowermen, Dusseldorf, Germany
[3] Univ Augsburg, Med Fac, Bezirkskrankenhaus Augsburg, Dept Psychiat Psychotherapy & Psychosomat, Augsburg, Germany
[4] Univ Hosp LMU Munich, Dept Psychiat & Psychotherapy, Munich, Germany
[5] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA
来源：
SCHIZOPHRENIA RESEARCH | 2021年 / 229卷
关键词：
Antipsychotic; Guideline; Long-term; Maintenance; Quality; Schizophrenia;
D O I：
10.1016/j.schres.2020.11.011
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [1] The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples
    Gaebel, Wolfgang
    Stricker, Johannes
    Riesbeck, Mathias
    SCHIZOPHRENIA RESEARCH, 2020, 225 : 4 - 14
  • [2] Long-term combination antipsychotic treatment in VA patients with schizophrenia
    Kreyenbuhl, Julie
    Valenstein, Marcia
    McCarthy, John F.
    Ganoczy, Dara
    Blow, Frederic C.
    SCHIZOPHRENIA RESEARCH, 2006, 84 (01) : 90 - 99
  • [3] Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia
    Siegel, SJ
    Winey, KI
    Gur, RE
    Lenox, RH
    Bilker, WB
    Ikeda, D
    Gandhi, N
    Zhang, WX
    NEUROPSYCHOPHARMACOLOGY, 2002, 26 (06) : 817 - 823
  • [4] Surgically Implantable Long-term Antipsychotic Delivery Systems for the Treatment of Schizophrenia
    Steven J Siegel
    Karen I Winey
    Raquel E Gur
    Robert H Lenox
    Warren B Bilker
    Debbie Ikeda
    Neel Gandhi
    Wen-Xiao Zhang
    Neuropsychopharmacology, 2002, 26 : 817 - 823
  • [5] A Systematic Review of the Need for Guideline Recommendations; Slow Tapering vs. Maintenance Dose in Long-Term Antipsychotic Treatment: 2022
    Potla, Shanthi
    Al Qabandi, Yousif
    Nandula, Savitri Aninditha
    Boddepalli, Chinmayi Sree
    Gutlapalli, Sai Dheeraj
    Lavu, Vamsi Krishna
    Abdelwahab, Rana Abdelwahab Mohamed
    Huang, Ruimin
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [6] Long-term studies of antipsychotic drugs in schizophrenia
    Lewander, T
    EUROPEAN PSYCHIATRY, 1996, 11 (03) : 127 - 134
  • [7] French Expert Consensus Guidelines for long-term treatment in schizophrenia
    Vanelle, JM
    ANNALES MEDICO-PSYCHOLOGIQUES, 2005, 163 (09): : 758 - 763
  • [8] Bone Density in Chronic Schizophrenia with Long-Term Antipsychotic Treatment: Preliminary Study
    Lee, Tae-Young
    Chung, Moon-Yong
    Chung, Hae-Kyung
    Choi, Jin-Hee
    Kim, Tae-Yong
    So, Hyung-Seok
    PSYCHIATRY INVESTIGATION, 2010, 7 (04) : 278 - 284
  • [9] Are Patients With Schizophrenia Better Off With Lifetime Antipsychotic Medication? Replication of a Naturalistic, Long-Term, Follow-Up Study of Antipsychotic Treatment
    Glick, Ira D.
    Zamora, Daisy
    Davis, John M.
    Suryadevara, Uma
    Goldenson, Andrea
    Kamis, Danielle
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (02) : 145 - 148
  • [10] What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
    Correll, Christoph U.
    Rubio, Jose M.
    Kane, John M.
    WORLD PSYCHIATRY, 2018, 17 (02) : 149 - 160
12345